Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$191.51 - $216.16 $133 Million - $150 Million
692,500 Added 323.3%
906,700 $192 Million
Q2 2023

Aug 11, 2023

BUY
$187.64 - $206.25 $40.2 Million - $44.2 Million
214,200 New
214,200 $41.2 Million
Q2 2022

Aug 10, 2022

BUY
$108.81 - $179.33 $1.09 Million - $1.79 Million
10,000 New
10,000 $1.77 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.